Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIP Chemotherapy + Systemic Chemotherapy in Colorectal Cancer Liver Metastases
NCT03366155Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2019
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine, dexamethasone in Colorectal cancer with liver metastases (CRLM), sponsored by National Cancer Institute. Started Jun 2019; status: completed.
02
Drugs
floxuridinedexamethasone
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03366155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03366155.